A Phase 3 Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC # 606869) in the Very High Risk Stratum

Grant

Date/time Interval

  • October 27, 2014 - June 30, 2020
  • Total Award Amount

  • 20500.00
  • Direct Costs

  • 16270.00
  • Sponsor Award Id

  • Contributor

  • Alva, Elizabeth   Investigator  
  • Aye, Jamie   Investigator  
  • Bemrich-Stolz, Christina   Investigator  
  • Bhatia M.D., Smita   Investigator  
  • Chewning III M.D., Joseph   Investigator  
  • Friedman M.D., Gregory   Investigator  
  • Galtarossa Xavier, Ana   Investigator  
  • Goldman M.D., Frederick   Investigator  
  • Haines, Hilary   Investigator  
  • Hilliard, Lee   Investigator  
  • Kutny M.D., Matthew   Investigator  
  • Lebensburger, Jeffrey   Investigator  
  • Madan-Swain Ph.D., Avi   Investigator  
  • Whelan M.D., Kimberly   Investigator  
  • Wolfson-Stockman M.D., Julie   Investigator